Guided Therapeutics (GTHP) EBT (2010 - 2025)
Guided Therapeutics' (GTHP) quarterly EBT came in at -$1.2 million in Q4 2025, down 86.81% year-on-year from -$9.2 million in Q4 2024, and down 64.15% quarter-over-quarter from -$742000.0 in Q3 2025.
Guided Therapeutics (GTHP) EBT (2010 - 2025) Analysis & Trends
Guided Therapeutics has disclosed EBT across 16 years of filings, most recently posting -$1.2 million for Q4 2025.
- EBT for Q4 2025 came in at -$1.2 million, down 86.81% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.2 million (down 32.31% YoY), and the FY2025 annual result was -$3.2 million, down 32.23% from the prior year.
- EBT came in at -$1.2 million for Q4 2025 at Guided Therapeutics, down from -$742000.0 in the prior quarter.
- In the past five years, EBT ranged from a high of $68000.0 in Q3 2021 to a low of -$1.8 million in Q4 2022.
- The 5-year median for EBT is -$693000.0 (2023), against an average of -$768650.0.
- Across the five-year window, EBT surged 84.68% in 2021 and slumped 1720.59% in 2022, its largest moves.
- Guided Therapeutics' EBT stood at -$444000.0 in 2021, then slumped by 306.98% to -$1.8 million in 2022, then surged by 78.64% to -$386000.0 in 2023, then slumped by 68.91% to -$652000.0 in 2024, then plunged by 86.81% to -$1.2 million in 2025.
- The last three EBT figures came in at -$1.2 million (Q4 2025), -$742000.0 (Q3 2025), and -$811000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.40 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 222.44 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 269.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 304.50 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | -1.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.22 Mn |
| Sep 30, 2025 | -742,000.00 |
| Jun 30, 2025 | -811,000.00 |
| Mar 31, 2025 | -427,000.00 |
| Dec 31, 2024 | -652,000.00 |
| Sep 30, 2024 | -654,000.00 |
| Jun 30, 2024 | -709,000.00 |
| Mar 31, 2024 | -402,000.00 |
| Dec 31, 2023 | -386,000.00 |
| Sep 30, 2023 | -677,000.00 |
| Jun 30, 2023 | -1.56 Mn |
| Mar 31, 2023 | -869,000.00 |
| Dec 31, 2022 | -1.81 Mn |
| Sep 30, 2022 | -1.10 Mn |
| Jun 30, 2022 | -926,000.00 |
| Mar 31, 2022 | -507,000.00 |
| Dec 31, 2021 | -444,000.00 |
| Sep 30, 2021 | 68,000.00 |
| Jun 30, 2021 | -1.03 Mn |
| Mar 31, 2021 | -517,000.00 |